Standout Papers

Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL 2006 2026 2012 2019 946
  1. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL (2006)
    Hagop M. Kantarjian, Francis J. Giles et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 28 from Science/Nature 75 standout
Sub-graph 1 of 19

Citing Papers

Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
2019 StandoutScience
Emerging Targets in Photopharmacology
2016 StandoutNobel
2 intermediate papers

Works of William Mietlowski being referenced

Phase III Study of Valspodar (PSC 833) Combined With Paclitaxel and Carboplatin Compared With Paclitaxel and Carboplatin Alone in Patients With Stage IV or Suboptimally Debulked Stage III Epithelial Ovarian Cancer or Primary Peritoneal Cancer
2008

Author Peers

Author Last Decade Papers Cites
William Mietlowski 495 287 342 835 677 32 1.7k
Aaron Weitzman 319 258 176 670 557 37 1.2k
Ji Yuan Wu 660 251 698 889 783 43 2.0k
Narayana I. Narasimhan 739 696 781 733 590 41 1.9k
Ron Paquette 387 201 532 1716 1133 23 2.2k
Edward C. Bradley 580 149 755 640 741 32 2.0k
Beatriz Moiraghi 303 98 210 1762 1504 41 2.0k
Marc S. Rudoltz 365 144 214 1374 1199 36 2.0k
Athena Countouriotis 314 111 172 1607 1391 21 1.9k
Chao Zhu 302 142 164 1788 1496 48 2.2k
Robert E. Rydell 277 237 376 1077 481 27 1.7k

All Works

Loading papers...

Rankless by CCL
2026